Overexpression of ABCB1 inducing multidrug resistance (MDR) desensitizes colon cancer cells to chemotherapy drugs with ABCB1 substrate specificity, resulting from enhanced stability of ABCB1 transcript via IGF2BP3 reading its m6A region [73]. Here, ABCB1 is linked to colonic neoplasm.